Datapile · Sector

Biotech funding

$7M raised across 1 disclosed Biotech rounds.

Latest round · May 21, 2026 · RSS

Total raised
$6.7M
Rounds
1
Countries
1
1 results
Cumulative USD raised · weekly
Geography · click to filter
Loading map…
Country ›United Kingdom ·1
Sector ›AI|AgTech|Biotech|ClimateTech|ConsumerTech|Crypto|Cybersecurity|DeepTech
Round ›Angel|Bridge|Debt|Debt and Equity|Early VC|Early-stage|Equity|Equity & Debt|Equity and Debt|Foundational|Funding Round|Grant|Growth|Growth Capital|Growth Equity|IPO|Late-stage|Minority Growth Investment|Pre-IPO|Pre-Series A|Pre-Series A2|Pre-Series A5|Pre-Series B|Pre-Series C|Pre-seed|Private Equity|Private Placement|Public Offering|QIP|Seed|Seed Extension|Seed and Follow-on|Seed and Series A|Series|Series A|Series A & B|Series A+|Series A++|Series A1|Series A4|Series B|Series B1|Series C|Series C+|Series D|Series D-2|Series E|Series F|Series G|Series Growth|Series H|Strategic
DateCompanyAmountRoundSectorCountryLead investors
May 21, 26Imperagen
Imperagen is a biotech company focused on enzyme engineering, utilizing quantum physics and AI to enhance the speed and efficiency of enzyme development. The company aims to revolutionize the traditional trial-and-error methods in enzyme engineering, making the process faster and more commercially viable for various industries, including pharmaceuticals and agriculture.
$6.7MSeedBiotechUnited KingdomPXN Ventures, IQ Capital, Northern Gritstone
Who funded these rounds

Every investor behind these 1 rounds is in Datapile.

Verified emails and LinkedIn profiles, filterable by stage, sector and check size.

Browse the investor directory →Start free · 5 unlocks / month
Weekly digest

Get the funding terminal in your inbox.

Filtered to your country and sector. One email per week.